Distinguished Speaker Series: The Business Behind Life-Changing Innovations

Presented by Johns Hopkins Carey Business School and Johns Hopkins Tech Ventures

Nothing Ventured, Nothing Gained
The Business of Transforming Life-Changing Discoveries

Scientific discovery and innovation can revolutionize society, but they must be scalable, profitable, and executable to have impact and provide lasting value for all. Join us for an insightful discussion on how scientific discoveries are transformed into life-changing interventions for the benefit of humanity with Christoph Lengauer, partner at Third Rock Ventures. Christy Wyskiel, senior advisor to the President of Johns Hopkins University for Innovation and Entrepreneurship and executive director of Johns Hopkins Technology Ventures, will moderate the discussion.

Christoph Lengauer, PhD, MS, MBA, is partner at Third Rock Ventures. As a venture capitalist, Lengauer has contributed to the discovery and development of four FDA-approved medicines and several drugs currently in clinical trials. He is dedicated to making a dramatic difference in patients’ lives through the discovery, launch, and building of companies at the intersection of science, strategy, business and medicine. Lengauer earned a PhD in Biology from Heidelberg University, an MS in Human Genetics from the University of Salzburg, and an MBA from Johns Hopkins University.

Christy Wyskiel, MBA, is senior advisor to the President of Johns Hopkins University for Innovation and Entrepreneurship. In this role, she also serves as the executive director of Johns Hopkins Technology Ventures, the division of the university responsible for technology transfer, industry research partnerships, and company incubation under the brand “FastForward.” Wyskiel is a seasoned entrepreneur, investor, and ecosystem builder with 25 years of experience primarily focused on the life sciences and healthcare industries.